HIV/AIDS
Selection of an HIV Variant in a Patient Co-infected with HIV and HBV during Baraclude (entecavir) treatment
Published in Hepatitis Weekly, March 19th, 2007
A case report has been received in which the selection of a human immunodeficiency virus (HIV) variant containing the M184V resistance substitution was documented during Baraclude(R) (entecavir) treatment for chronic hepatitis B virus (HBV) infection in an HIV/HBV co-infected patient who was not simultaneously receiving highly active anti-retroviral therapy (HAART). Current treatment guidelines recommend Baraclude as an option for treatment of HBV in the HIV/HBV co-infected adult patient who does not qualify for HAART, however, in light of the newly reported case history provided, Bristol-Myers Squibb advises caution if Baraclude is used in this setting.
Keywords:...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2007-03-19)
More Articles from Hepatitis Weekly
- Hepatocellular Cancer
Outcomes for patients with hepatitis B who need liver transplants - Hepatitis B Virus
Idenix Announces Thirteen Data Presentations at the 2007 European Association For the Study of the Liver - Hepatitis B Virus
Sebivo approved in China for treatment of chronic hepatitis B, the nation's second leading cause of death - Hepatitis C Virus
Nautilus Biotech and HanAll Pharmaceutical Announce License Agreement to Develop Three Nautilus Biotech Products in South Korea - Hepatitis C Virus
Pharmasset Initiates Multiple Ascending Dose Study of R7128 in Patients Chronically Infected with HCV Genotype 1 - Hepatitis E Virus
Study published in New England Journal of Medicine: Vaccine 95.5% effective against neglected hepatitis E - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
